| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Virpax Pharmaceuticals, Inc. | Chief Executive Officer, Director, 10%+ Owner | Stock Option (right to buy) | 125,000 | 25 Jan 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VRPX | Virpax Pharmaceuticals, Inc. | 25 Jan 2023 | 1 | $0 | 4/A | Chief Executive Officer, Director, 10%+ Owner | 07 Feb 2023, 20:30 |
| VRPX | Virpax Pharmaceuticals, Inc. | 18 May 2022 | 1 | +$101,505 | 4 | Chief Executive Officer, Director | 20 May 2022, 18:15 |
| VRPX | Virpax Pharmaceuticals, Inc. | 31 Jan 2022 | 1 | $0 | 4/A | Chief Executive Officer, Director, 10%+ Owner | 25 Feb 2022, 15:44 |
| VRPX | Virpax Pharmaceuticals, Inc. | 18 Nov 2021 | 1 | +$100,249 | 4 | Chief Executive Officer, Director, 10%+ Owner | 22 Nov 2021, 17:00 |